BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Trichostatin A
,
rs2230926
,
ERBB2
,
cell-cell adhesion
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rifater
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
MALT lymphoma gene expression profiling from samples with or without translocations
Cutaneous squamous cell carcinoma and actinic keratoses
Expression analysis splenic marginal zone lymphomas
Explore Curated Studies Results
Literature
Most Relevant Literature
Rifat Atun: looking at the bigger picture.
The Mitragyna speciosa (Kratom) Genome: a resource for data-mining potent pharmaceuticals that impac…
Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case re…
Digital Education for Health Professionals: An Evidence Map, Conceptual Framework, and Research Agen…
Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Revea…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prosp…
Pharmacokinetic Study for Anti-tuberculosis Drugs
Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anter…
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ